// App-Quantinova.ai

: Fractional exhaled nitric oxide (FeNO) suppression with directly observed inhaled corticosteroid therapy: does it make a difference to patient outcomes?

Researchers

Presenter

  • Shoaib Faruqi

Principal Investigators

  • Joanne Thompson

  • Terry Robinson

  • Karen Watkins

  • Helena Cummings

  • Nicola Jackson

  • Anoop Prakash

  • Michael Crooks

Medical Centers

  • Hull and East Yorkshire NHS Trust, Cottingham, United Kingdom

  • Department of Rheumatology, Harrogate and District Foundation Trust, Harrogate, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Nitric oxide

  • Fluticasone

  • Fluticasone furoate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved